Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts  Satoshi Yamashiro, MDa,b, Katsuhiko Noguchi,

Slides:



Advertisements
Similar presentations
The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.
Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Prevention of allograft heart valve failure in a rat model Jean-Francois Légaré, MDa,b, David B. Ross, MDa, Thomas B. Issekutz, MDa,b,c, Wendy Ruigrok,
Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model Johanna Bayer, MD, Nitin A. Das, MD, Clinton E. Baisden, MD, Meenakshi.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Effects of myocardial ischemia on the release of cardiac troponin I in isolated rat hearts  Sidney Chocron, MDa, Kifah Alwan, MDa, Gerard Toubin, MDb,
Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat  Ryuzo Bessho, MD, PhD, David J. Chambers,
B. Zane Atkins, MD, Scott C. Silvestry, MD, Ravi N. Samy, MD, Ashish S
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation  Haitham J. Abunasra, FRCS,
Early reperfusion with warm, polarizing adenosine–lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage  Donna M. Rudd,
Right internal thoracic artery or saphenous vein grafting
Victor van Berkel, MD, PhD 
Long-term myocardial preservation: effects of hyperkalemia, sodium channel, and NA+/K+/2CL- cotransport inhibition on extracellular potassium accumulation.
A new approach: Ischemic mitral regurgitation guidelines by and for surgeons  Patrick M. McCarthy, MD  The Journal of Thoracic and Cardiovascular Surgery 
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
An economic evaluation of lung transplantation
Nitric oxide inhalation prompts weaning from the right ventricular assist device: Evaluation under continuous-flow biventricular assistance  George J.
Pediatric pacemaker infections: Twenty years of experience
The lord of the rings  Antonio Miceli, MD, PhD 
Effects of cardioplegia on vascular function and the “no-reflow" phenomenon after ischemia and reperfusion: Studies in the isolated blood-perfused rat.
Gastric conduit revision after esophagectomy: The raising of Lazarus
Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated.
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na+/H+ exchange  Manuel Castellá, MDa, Gerald D. Buckberg, MDa,
Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial.
Support Your Specialty
It's not “just a shunt” but sometimes it should be…
Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading  Hajime Imura, MD, Hua Lin, MSc, Elinor.
Ashok Muniappan, MD  The Journal of Thoracic and Cardiovascular Surgery 
Pulmonary metabolism of endothelin 1 during on-pump and beating heart coronary artery bypass operations  Patrick Mathieu, MDa, Jocelyn Dupuis, MD, PhDb,
Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model  Ilhan Inci, MDa, André Dutly,
Experimental study of intermittent crossclamping with fibrillation and myocardial protection: Reduced injury from shorter cumulative ischemia or intrinsic.
Ischemic preconditioning with opening of mitochondrial adenosine triphosphate– sensitive potassium channels or Na+/H+ exchange inhibition: Which is the.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Aging reduces postischemic recovery of coronary endothelial function
David C. Stuesse, MDa, George D. Giraud, MD, PhDb, Angelo A
Fructose-1,6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs  Pekka Romsi, MDa, Timo Kaakinen, MSa, Kai Kiviluoma, MD,
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Protein kinase C isoform–dependent myocardial protection by ischemic preconditioning and potassium cardioplegia  Kejie Lu, MD*, Hajime Otani, MD, Tadashi.
Commentary: Do the right thing! Ethical versus legal
Tolerance to ischemia and hypoxia is reduced in aged human myocardium
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Subodh Verma, MD, PhDa, Fina Lovren, PhDb, Aaron S
Heart transplantation with donors fifty years of age and older
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Effects of an Angiotensin II Antagonist on Ischemic and Nonischemic Isolated Rat Hearts  Yosef Paz, Jacob Gurevitch, Inna Frolkis, Menachem Matsa, Amir.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tai Ji: The law of inflammatory response
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
When should the elephant (frozen elephant trunk) enter the room (aorta)?  Frank A. Baciewicz, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume.
Building a clinical program in a single institution
Changes in coronary vessel resistance during postischemic reperfusion and effectiveness of nitroglycerin  Gerhard A. Kalweit, MDa, Jochen D. Schipke,
Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity*  W.Charles Sternbergh, MD, Raymond.
Early effects of hypothyroidism on the contractile function of the rat heart and its tolerance to hypothermic ischemia  Manuel Galiñanes, MD, PhD, Ryszard.
“The more things change…”: The challenges ahead
S. Fortier, MDa, R. G. Demaria, MD, PhDa,c, G. B. Pelletier, MDb, M
Myocardial protection by ischemic preconditioning and δ-opioid receptor activation in the isolated working rat heart  Matthias Karck, MDa, Satonori Tanaka,
Toward a more rational approach in treating type B aortic dissection
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Presentation transcript:

Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts  Satoshi Yamashiro, MDa,b, Katsuhiko Noguchi, PhDa, Toshihiro Matsuzaki, MD, PhDa, Kanako Miyagi, BSa, Junko Nakasone, PhDa, Mayuko Sakanashi, MSa, Kageharu Koja, MD, PhDb, Matao Sakanashi, MD, PhDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 124, Issue 4, Pages 775-784 (October 2002) DOI: 10.1067/mtc.2002.124393 Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Time course of changes in LVDP (A), mean CF (B), maximum LV dp/dt (C), and minimum LV dp/dt (D) in the nonischemic KHS group (n = 8, open triangles), the nonischemic BH4 group (n = 8, filled triangles), the ischemic KHS group (n = 8, open circles), the ischemic BH4 (1.25 mg/mL) group (n = 8, filled circles), the ischemic low BH4 (0.6 mg/mL) group (n = 8, open diamonds), the Vit C (0.49 mg/mL) group (n = 6, filled diamonds), and the SOD/catalase (2000 U/mL each) group (n = 8, open squares). Values are expressed as percentages of corresponding baseline values. Each value represents mean ± SE. ***P <.001 versus ischemic KHS group. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 775-784DOI: (10.1067/mtc.2002.124393) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Time course of change in LVEDP (A), time to onset of ischemic contracture (B), and peak LVEDP during ischemia (C). Each value represents mean ± SE. *P <.05, **P <.01, and ***P <.001 versus ischemic KHS group. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 775-784DOI: (10.1067/mtc.2002.124393) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 LDH activity in coronary effluent in the nonischemic KHS group (n = 7), the nonischemic BH4 group (n = 7), the ischemic KHS group (n = 7), the ischemic BH4 group (n = 7), the ischemic low BH4 group (n = 7), the Vit C group (n = 6), and the SOD/catalase group (n = 8). Each value represents mean ± SE. NS, No significant difference. ***P <.001 versus ischemic KHS group; †P <.05 and †††P <.001 versus nonischemic KHS group. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 775-784DOI: (10.1067/mtc.2002.124393) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 Percentage of NOx level in the coronary effluent after ischemia. Values are expressed as percentages of corresponding baseline values before ischemia. Each value represents mean ± SE. ***P <.001 versus ischemic KHS group; ††P <.01 and †††P <.001 versus nonischemic KHS group. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 775-784DOI: (10.1067/mtc.2002.124393) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions